ChiCTR2400093764 版本V1.1 版本创建时间2024/12/11 16:25:13 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400093764 

最近更新日期:

Date of Last Refreshed on:

2024-12-11 16:24:03 

注册时间:

Date of Registration:

2024-12-11 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

一种新型睡眠监测设备诊断睡眠呼吸障碍的有效性验证研究

Public title:

Validation study of a new type of sleep monitoring device for diagnosis of sleep-disordered breathing

注册题目简写:

English Acronym:

研究课题的正式科学名称:

一种新型睡眠监测设备诊断睡眠呼吸障碍的有效性验证研究

Scientific title:

Validation study of a new type of sleep monitoring device for diagnosis of sleep-disordered breathing

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

雷文斌 

研究负责人:

雷文斌 

Applicant:

Wenbin Lei 

Study leader:

Wenbin Lei 

申请注册联系人电话:

Applicant telephone:

+86 13922113299

研究负责人电话:

Study leader's
telephone:

+86 13922113299

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

leiwb@mail.sysu.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

leiwb@mail.sysu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广州市中山二路58号

研究负责人通讯地址:

广州市中山二路58号

Applicant address:

No. 58 Zhongshan 2nd Road, Guangzhou City

Study leader's address:

No. 58 Zhongshan 2nd Road, Guangzhou City

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中山大学附属第一医院

Applicant's institution:

The First Affiliated Hospital,Sun Yat-sen University

研究负责人所在单位:

中山大学附属第一医院

Affiliation of the Leader:

The First Affiliated Hospital,Sun Yat-sen University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

伦审临[2024]199 号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中山大学附属第一医院伦理委员会

Name of the ethic committee:

Ethics Committee of The First Affiliated Hospital,Sun Yat-sen University

伦理委员会批准日期:

Date of approved by ethic committee:

2024-04-10 00:00:00

伦理委员会联系人:

陈湛勇

Contact Name of the ethic committee:

Chen ZhanYong

伦理委员会联系地址:

广州市中山二路58号

Contact Address of the ethic committee:

No. 58 Zhongshan 2nd Road, Guangzhou City

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 20 87334871

伦理委员会联系人邮箱:

Contact email of the ethic committee:

chenzhy233@mail.sysu.edu.cn

研究实施负责(组长)单位:

中山大学附属第一医院

Primary sponsor:

The First Affiliated Hospital,Sun Yat-sen University

研究实施负责(组长)单位地址:

广州市中山二路58号

Primary sponsor's address:

No. 58 Zhongshan 2nd Road, Guangzhou City

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

Country:

China

Province:

Guangdong

City:

单位(医院):

中山大学附属第一医院

具体地址:

广州市中山二路58号

Institution
hospital:

The First Affiliated Hospital,Sun Yat-sen University

Address:

No. 58 Zhongshan 2nd Road, Guangzhou City

经费或物资来源:

广州市越秀区星云医疗器械有限公司

Source(s) of funding:

Guangzhou Yuexiu District Xingyun medical equipment Co., LTD

研究疾病:

睡眠呼吸障碍  

Target disease:

Sleep-disordered breathing

研究疾病代码:

Target disease code:

研究类型:

诊断试验

Study type:

Diagnostic test

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

诊断试验诊断准确性 

Study design:

Diagnostic test for accuracy 

研究目的:

探究一种新型睡眠监测设备与多导睡眠监测(PSG)相比诊断睡眠呼吸障碍疾病的真实性、可靠性和预测值。  

Objectives of Study:

To explore the validation, precision and predictive value of a new sleep monitoring device compared with polysomnography (PSG) in diagnosing sleep disordered breathing.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.可配合完成整夜多导睡眠监测(PSG);
2.总睡眠时间(TST)≥4小时;
3.快速眼动(REM)睡眠时间≥15min;

Inclusion criteria

1.Complete overnight polysomnographic sleep monitoring (PSG); 2.Total sleep time (TST) >=4 hours; 3.Rapid eye movement (REM) sleep duration >=15min;

排除标准:

1.基本信息不完整;
2.沟通障碍,不能配合;

Exclusion criteria:

1.Basic information is incomplete;
2.Communication breakdown, inability to cooperate;

研究实施时间:

Study execute time:

From 2024-04-15 00:00:00 To 2027-04-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-04-15 00:00:00 To 2027-04-30 00:00:00

诊断试验:

Diagnostic Tests:

金标准或参考标准(即可准确诊断某疾病的单项方法或多项联合方法,在本研究中用于诊断是否有该病的临床参考标准):

整夜多导睡眠监测(PSG)呼吸暂停低通气指数(Apnea hypopnea index, AHI)>=5(次/小时)

Gold Standard or Reference Standard (The clinical reference standards required to establish the presence or absence of the target condition in the tested population in present study):

Overnight PSG apnea hypopnea index (AHI) >=5 (times/hour)

指标试验(即本研究的待评估诊断试验,无论为方法、生物标志物或设备,均请列出名称):

整夜毫米波雷达睡眠呼吸监测(Tsingray)收集睡眠监测指标,包括呼吸暂停低通气指数(Apnea hypopnea index, AHI)、平均动脉血氧饱和度(SaO2)、最低 SaO2 、微觉醒指数(Arousal index, Ari)、睡眠结构总结、睡眠分期等。

Index test:

Overnight millimeter-wave radar sleep breathing monitoring (Tsingray) collects sleep monitoring indicators, It includes Apnea hypopnea index (AHI), mean arterial oxygen saturation (SaO2), minimum SaO2, Arousal index (Ari), summary of sleep structure, sleep stages, etc.

目标人群(可以是某种疾病患者或正常人群,详细描述其疾病特征,注意应纳入符合分布特点的全序列病例,具有良好的代表性)

来院就诊怀疑有睡眠呼吸障碍的人群

例数:

Sample size:

10000

Target condition (The target condition is a particular disease or disease stage that the index test will be intended to identify. Please specify the characteristics in detail; the population should has a complete spectrum and good representative):

People who came to the hospital with suspected sleep disordered breathing

容易混淆的疾病人群(即与目标疾病不易区分的一种或多种不同疾病,应避免采用正常人群对照的病例-对照设计):

例数:

Sample size:

0

Population with condition difficult to distinguish from the target condition, the normal population in a case-control study design should be avoid:

None

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

中山大学附属第一医院 

单位级别:

三级甲等 

Institution
hospital:

The First Affiliated Hospital, Sun Yat-sen University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广东 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

中山大学附属第三医院 

单位级别:

三级甲等 

Institution
hospital:

The Third Affiliated Hospital Sun Yat-sen University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广东 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

中山大学附属第五医院 

单位级别:

三级甲等 

Institution
hospital:

The Fifth Affiliated Hospital, Sun Yat-Sen University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广东 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

中山大学附属第六医院 

单位级别:

三级甲等 

Institution
hospital:

The Sixth Affiliated Hospital, Sun Yat-sen University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广东 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

中山大学附属第七医院 

单位级别:

三甲 

Institution
hospital:

The Seventh Affiliated Hospital of Sun Yat sen University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

呼吸暂停低通气指数

指标类型:

主要指标

Outcome:

Apnea hypopnea index, AHI

Type:

Primary indicator

测量时间点:

睡眠监测期间

测量方法:

通过多导睡眠监测或毫米波雷达睡眠监测呼吸暂停与低通气

Measure time point of outcome:

Sleep monitoring period

Measure method:

Apnea and hypopnea were monitored by polysomnography or millimeter-wave radar

指标中文名:

睡眠结构

指标类型:

次要指标

Outcome:

sleep structure

Type:

Secondary indicator

测量时间点:

睡眠监测期间

测量方法:

通过多导睡眠监测或毫米波雷达睡眠监测睡眠分期、总睡眠时长、睡眠后清醒时长形成睡眠结构

Measure time point of outcome:

Sleep monitoring period

Measure method:

The sleep structure was formed by monitoring sleep stages, total sleep duration and post-sleep wakefulness duration by polysomnography or millimeter-wave radar

指标中文名:

准确度

指标类型:

次要指标

Outcome:

Accuracy

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

灵敏度

指标类型:

次要指标

Outcome:

Sensitivity

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

特异性

指标类型:

次要指标

Outcome:

Specificity

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 16 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2027年5月1日以后,通过邮件共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

After 1st May 2027, data will be shared via email.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

EDC

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2024-12-11 16:21:49